Clinical care information and other considerations for specific patient types This guidance is intended to inform pediatric healthcare providers of up-to-date information about children with...

Coronavirus disease 2019 (COVID-19) is a respiratory illness (see list of symptoms) caused by a virus called SARS-CoV-2. Here’s what we currently know: The main...

As of June 30, 2021, 33.5 million persons in the United States had received a diagnosis of COVID-19 (1). Although most patients infected with SARS-CoV-2,...

In December 2020, the Food and Drug Administration (FDA) issued Emergency Use Authorizations (EUAs) for the Pfizer-BioNTech COVID-19 (BNT162b2) vaccine and the Moderna COVID-19 (mRNA-1273)...

SARS-CoV-2, the virus that causes COVID-19, can be spread by exposure to droplets and aerosols of respiratory fluids that are released by infected persons when...

This information is intended for a general audience. Healthcare providers should see the Post-COVID Conditions: Information for Healthcare Providers webpage and the interim guidance on...

For public awareness and in the interest of transparency, CDC is providing timely updates on the following serious adverse events of interest: Anaphylaxis after COVID-19...

The CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay is a real-time reverse-transcription polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza...

Step 1: Document Prevaccination Actions Are Complete Roles: Clinic Administrator and Healthcare Professional Prevaccination Actions will vary by clinic but can include things such as...

Today, public health and medical experts from the U.S. Department of Health and Human Services (HHS) released the following statement on the Administration’s plan for...

NOTICE: HHS announced a plan to begin offering COVID-19 vaccine booster shots this fall. CDC’s independent advisory committee, the Advisory Committee on Immunization Practices, will...